Incyte (INCY) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.86% |
| Dec 31, 2025 | -3.40% |
| Sep 30, 2025 | 0.53% |
| Jun 30, 2025 | 3.83% |
| Mar 31, 2025 | 1.81% |
| Dec 31, 2024 | 2.77% |
| Sep 30, 2024 | 16.97% |
| Jun 30, 2024 | 11.36% |
| Mar 31, 2024 | -25.19% |
| Dec 31, 2023 | -26.61% |
| Sep 30, 2023 | -26.56% |
| Jun 30, 2023 | -29.14% |
| Mar 31, 2023 | -33.69% |
| Dec 31, 2022 | -15.22% |
| Jun 30, 2022 | -17.09% |
| Mar 31, 2022 | -17.18% |
| Dec 31, 2021 | -17.75% |
| Sep 30, 2021 | -18.42% |
| Jun 30, 2021 | -88.02% |
| Mar 31, 2021 | -81.37% |
| Dec 31, 2020 | -15.48% |
| Sep 30, 2020 | -10.63% |
| Jun 30, 2020 | -37.71% |
| Mar 31, 2020 | -36.52% |
| Dec 31, 2019 | -37.84% |
| Jun 30, 2019 | -51.50% |
| Mar 31, 2019 | -24.94% |
| Dec 31, 2018 | -26.66% |
| Sep 30, 2018 | -45.52% |
| Jun 30, 2018 | 10.74% |
| Mar 31, 2018 | 7.99% |
| Dec 31, 2017 | -37.21% |
| Sep 30, 2017 | -49.63% |
| Jun 30, 2017 | -6.16% |
| Mar 31, 2017 | -5.40% |
| Dec 31, 2016 | -19.66% |
| Sep 30, 2016 | -25.83% |
| Jun 30, 2016 | -20.68% |
| Mar 31, 2016 | -44.23% |
| Dec 31, 2015 | -45.79% |
| Sep 30, 2015 | -22.36% |
| Jun 30, 2015 | -18.91% |
| Mar 31, 2015 | -21.34% |
| Dec 31, 2014 | -17.71% |
| Sep 30, 2014 | -6.46% |
| Jun 30, 2014 | -11.80% |
| Mar 31, 2014 | -4.45% |
| Dec 31, 2013 | -3.62% |
| Sep 30, 2013 | 9.19% |
| Jun 30, 2013 | 12.50% |
| Mar 31, 2013 | 12.60% |